BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37450087)

  • 21. Impact of S100A8/A9 expression on prostate cancer progression in vitro and in vivo.
    Grebhardt S; Müller-Decker K; Bestvater F; Hershfinkel M; Mayer D
    J Cell Physiol; 2014 May; 229(5):661-71. PubMed ID: 24122301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. S100A8/A9 activate key genes and pathways in colon tumor progression.
    Ichikawa M; Williams R; Wang L; Vogl T; Srikrishna G
    Mol Cancer Res; 2011 Feb; 9(2):133-48. PubMed ID: 21228116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. β-1,3-Galactosyl-
    Sumardika IW; Youyi C; Kondo E; Inoue Y; Ruma IMW; Murata H; Kinoshita R; Yamamoto KI; Tomida S; Shien K; Sato H; Yamauchi A; Futami J; Putranto EW; Hibino T; Toyooka S; Nishibori M; Sakaguchi M
    Oncol Res; 2018 Apr; 26(3):431-444. PubMed ID: 28923134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TLR4 and RAGE conversely mediate pro-inflammatory S100A8/9-mediated inhibition of proliferation-linked signaling in myeloproliferative neoplasms.
    Kovačić M; Mitrović-Ajtić O; Beleslin-Čokić B; Djikić D; Subotički T; Diklić M; Leković D; Gotić M; Mossuz P; Čokić VP
    Cell Oncol (Dordr); 2018 Oct; 41(5):541-553. PubMed ID: 29946821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. S100A8 facilitates cholangiocarcinoma metastasis via upregulation of VEGF through TLR4/NF‑κB pathway activation.
    Pan S; Hu Y; Hu M; Xu Y; Chen M; Du C; Cui J; Zheng P; Lai J; Zhang Y; Bai J; Jiang P; Zhu J; He Y; Wang J
    Int J Oncol; 2020 Jan; 56(1):101-112. PubMed ID: 31746424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated levels of proliferating and recently migrated tumor-associated macrophages confer increased aggressiveness and worse outcomes in breast cancer.
    Mukhtar RA; Moore AP; Tandon VJ; Nseyo O; Twomey P; Adisa CA; Eleweke N; Au A; Baehner FL; Moore DH; McGrath MS; Olopade OI; Gray JW; Campbell MJ; Esserman LJ
    Ann Surg Oncol; 2012 Nov; 19(12):3979-86. PubMed ID: 22622474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smad4 loss is associated with fewer S100A8-positive monocytes in colorectal tumors and attenuated response to S100A8 in colorectal and pancreatic cancer cells.
    Ang CW; Nedjadi T; Sheikh AA; Tweedle EM; Tonack S; Honap S; Jenkins RE; Park BK; Schwarte-Waldhoff I; Khattak I; Azadeh B; Dodson A; Kalirai H; Neoptolemos JP; Rooney PS; Costello E
    Carcinogenesis; 2010 Sep; 31(9):1541-51. PubMed ID: 20622003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies.
    Wagner NB; Weide B; Gries M; Reith M; Tarnanidis K; Schuermans V; Kemper C; Kehrel C; Funder A; Lichtenberger R; Sucker A; Herpel E; Holland-Letz T; Schadendorf D; Garbe C; Umansky V; Utikal J; Gebhardt C
    J Immunother Cancer; 2019 Dec; 7(1):343. PubMed ID: 31806053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction between S100A8/A9 and annexin A6 is involved in the calcium-induced cell surface exposition of S100A8/A9.
    Bode G; Lüken A; Kerkhoff C; Roth J; Ludwig S; Nacken W
    J Biol Chem; 2008 Nov; 283(46):31776-84. PubMed ID: 18786929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function.
    Gielen PR; Schulte BM; Kers-Rebel ED; Verrijp K; Bossman SA; Ter Laan M; Wesseling P; Adema GJ
    Neuro Oncol; 2016 Sep; 18(9):1253-64. PubMed ID: 27006175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High S100A8 and S100A12 protein expression is a favorable prognostic factor for survival of oropharyngeal squamous cell carcinoma.
    Funk S; Mark R; Bayo P; Flechtenmacher C; Grabe N; Angel P; Plinkert PK; Hess J
    Int J Cancer; 2015 May; 136(9):2037-46. PubMed ID: 25302747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.
    Burandt E; Jens G; Holst F; Jänicke F; Müller V; Quaas A; Choschzick M; Wilczak W; Terracciano L; Simon R; Sauter G; Lebeau A
    Breast Cancer Res Treat; 2013 Feb; 137(3):745-53. PubMed ID: 23322234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. S100A8 Expression May Have a Prognostic Value in CCRCC Reflecting TNM Staging and Fuhrman Nuclear Grade.
    An HJ; Koh HM; Song DH
    Anticancer Res; 2019 Sep; 39(9):4681-4685. PubMed ID: 31519567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjusting breast cancer patient prognosis with non-HER2-gene patterns on chromosome 17.
    Kotoula V; Bobos M; Alexopoulou Z; Papadimitriou C; Papadopoulou K; Charalambous E; Tsolaki E; Xepapadakis G; Nicolaou I; Papaspirou I; Aravantinos G; Christodoulou C; Efstratiou I; Gogas H; Fountzilas G
    PLoS One; 2014; 9(8):e103707. PubMed ID: 25098819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of S100A8 expression on kidney cancer progression and molecular docking studies for kidney cancer therapeutics.
    Mirza Z; Schulten HJ; Farsi HM; Al-Maghrabi JA; Gari MA; Chaudhary AG; Abuzenadah AM; Al-Qahtani MH; Karim S
    Anticancer Res; 2014 Apr; 34(4):1873-84. PubMed ID: 24692722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion.
    Moon A; Yong HY; Song JI; Cukovic D; Salagrama S; Kaplan D; Putt D; Kim H; Dombkowski A; Kim HR
    Mol Cancer Res; 2008 Oct; 6(10):1544-53. PubMed ID: 18922970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer.
    Staaf J; Jönsson G; Ringnér M; Vallon-Christersson J; Grabau D; Arason A; Gunnarsson H; Agnarsson BA; Malmström PO; Johannsson OT; Loman N; Barkardottir RB; Borg A
    Breast Cancer Res; 2010; 12(3):R25. PubMed ID: 20459607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical significance of S100A8 and S100A9 expression in gastric cancer].
    Hu Y; Fan B; Zhang LH; Cheng XJ; Niu ZJ; Ji JF
    Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(42):3369-74. PubMed ID: 24418034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intranasal Delivery of Recombinant S100A8 Protein Delays Lung Cancer Growth by Remodeling the Lung Immune Microenvironment.
    Wong SW; McCarroll J; Hsu K; Geczy CL; Tedla N
    Front Immunol; 2022; 13():826391. PubMed ID: 35655772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular subtypes of breast cancer in South Asian population by immunohistochemical profile and Her2neu gene amplification by FISH technique: association with other clinicopathologic parameters.
    Hashmi AA; Edhi MM; Naqvi H; Khurshid A; Faridi N
    Breast J; 2014; 20(6):578-85. PubMed ID: 25219294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.